Uncategorized
VIDEO: KPI-121 shows promising results as first-line dry eye therapy
In this video from the virtual American Society of Cataract and Refractive Surgery meeting, Edward J. Holland, MD, director of cornea services at Cincinnati Eye Institute and professor of ophthalmology at the University of Cincinnati, discusses his poster on phase 2 results with KPI-121 (Kala Pharmaceuticals) as a potential new topical therapy for the treatment of dry eye.